Sex differences in responses to myocardial ischemia have been described, but whether
cardiomyocyte function is influenced by sex in the setting of ischemia and reperfusion has …

Menopausal status is a risk factor for coronary artery disease death, but the mechanism
underlying this association is uncertain. To test whether estrogen ameliorates the effects of …

Abstract Ischemic Heart Disease (IHD) is a clinical condition characterized by insufficient
blood flow to the cardiac tissue, and the consequent inappropriate oxygen and nutrients …

Heart failure seems to be a different entity in women than in men because of gender-related
differences in the cardiovascular system. Myocardial hypertrophy is one independent risk …

The study was designed to investigate the effect of progesterone and its gender based
variation on myocardial ischemia/reperfusion (I/R) injury in rats. Adult Sprague Dawley rats …

In the first four decades of life, women are protected from cardiovascular disease (CVD)
compared with men, perhaps making women the stronger sex. Over the next five to ten …

The role of estrogens during myocardial ischemia has been extensively studied. However,
effects of a standard hormone replacement therapy including 17β-estradiol (E2) combined …

Background: Phytoestrogens are a class of natural compounds that have structural
similarities to estrogens. They have been identified to confer potent cardioprotective effects …

OBJECTIVES The purpose of this study was to examine whether endogenous estrogen
deficiency induced by ovariectomy affects chronic left ventricular dysfunction post …

The cardiovascular effects of estrogen have recently become a focus of basic and clinical
cardiovascular medicine because of the multiplicity of its beneficial effects. Various basic …